Karolinska Institutet (KI), founded in 1810, is Sweden’s only university specifically focusing on biomedical sciences (ki.se/en). KI ranks as one of the world’s leading medical universities, thanks in part to the quality of its research activities, that today accounts for 40 percent of all medical research in Sweden.
Karolinska Institutet, Sweden
Jussi Taipale is a Professor of Medical Systems Biology at the Department of Medical Biochemistry and Biophysics (MBB), Karolinska Institutet, Sweden. The Taipale research group has extensive experience in regulatory genomics, systems biology and genome-scale technologies. In DECIDER, the Taipale group is responsible for the gene regulation studies of high-grade serous ovarian cancer cells. The main strength of the group is in systems biology, genomics and molecular biology of signal transduction and growth control. The group focuses on high-throughput screening using cDNA and RNA interference, computational and experimental methods to identify causative regulatory mutations in non-protein coding DNA, as well as method development in quantitative RNA-sequencing and systems biology of lineage determination. ki.se/en/mbb/jussi-taipale-group